Aeglea BioTherapeutics (AGLE) Q2 2023 Earnings

Aug 11Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2023
-1.66
-1.16
-0.65
-0.15

Details

Expected EPS
-0.15
Actual EPS
-1.66
Surprise EPS
-1.51
Surprise Percent
-1,006.67%

Description

⁨Aeglea BioTherapeutics⁩ (⁦AGLE⁩) has reported earnings of ⁦-1.66⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts